← back to search

Nicholas Chew

National Heart Centre Singapore · SG
Area of research
Cardiology and Cardiovascular Medicine · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors, and Diabetes, Cardiovascular Risks, and Lipoproteins.
h-index
50
citations
13,550
works
367
NIH funding
primary concept
Medicine
email

Recent publications

The epidemiology and burden of cardiovascular diseases in countries of the Association of Southeast Asian Nations (ASEAN), 1990–2021: findings from the Global Burden of Disease Study 2021
The Lancet Public Health 2025cited by 29position: middledoi
The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050
Journal of the American College of Cardiology 2025cited by 25position: lastdoi
Performance of PREVENT and pooled cohort equations for predicting 10-Year ASCVD risk in the UK Biobank
American Journal of Preventive Cardiology 2025cited by 13position: middledoi
Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety
Cardiovascular Diabetology 2025cited by 8position: lastdoi
Beyond Cholesterol: Unraveling Residual Lipidomic Risk in Cardiovascular Health
Current Atherosclerosis Reports 2025cited by 7position: middledoi
The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
Nature Reviews Cardiology 2025cited by 6position: firstdoi
Non-invasive scoring systems of liver fibrosis predict prognosis in the cohort with myocardial infarction
Scientific Reports 2025cited by 6position: lastdoi
Population‐Based Study on the Coexistence of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Chronic Kidney Disease
Journal of the American Heart Association 2025cited by 6position: lastdoi
Global burden of cardiovascular diseases: projections from 2025 to 2050
European Journal of Preventive Cardiology 2024cited by 537position: middledoi
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
Circulation 2024cited by 102position: firstdoi
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
The Lancet Regional Health - Western Pacific 2024cited by 74position: lastdoi
Efficacy and safety of tirzepatide, <scp>GLP</scp>‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Obesity 2024cited by 57position: middledoi
Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles
Journal of Extracellular Vesicles 2024cited by 43position: middledoi
The Global Epidemic of Metabolic Fatty Liver Disease
Current Cardiology Reports 2024cited by 35position: middledoi
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Diabetes Research and Clinical Practice 2024cited by 35position: firstdoi
Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation
Journal of Medical Internet Research 2024cited by 29position: middledoi
Association of Lipoprotein(a) With Major Adverse Cardiovascular Events Across hs-CRP
JACC Advances 2024cited by 20position: middledoi
The global burden of metabolic disease: Data from 2000 to 2019
Cell Metabolism 2023cited by 741position: firstdoi
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
EClinicalMedicine 2023cited by 289position: lastdoi
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019
Metabolism 2023cited by 155position: lastdoi
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Clinical Gastroenterology and Hepatology 2023cited by 122position: middledoi
Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis
International Journal of Obesity 2023cited by 79position: middledoi
Epicardial Adipose Tissue Assessed by Computed Tomography and Echocardiography Are Associated With Adverse Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Circulation Cardiovascular Imaging 2023cited by 69position: lastdoi
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study
Circulation Cardiovascular Quality and Outcomes 2023cited by 40position: lastdoi
Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes Mellitus: an Umbrella review of systematic reviews
European Journal of Preventive Cardiology 2023cited by 34position: lastdoi
Injectable liposomal docosahexaenoic acid alleviates atherosclerosis progression and enhances plaque stability
Journal of Controlled Release 2023cited by 34position: middledoi
Effectiveness of Combined Health Coaching and Self-Monitoring Apps on Weight-Related Outcomes in People With Overweight and Obesity: Systematic Review and Meta-analysis
Journal of Medical Internet Research 2023cited by 34position: middledoi
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort
The Lancet Regional Health - Western Pacific 2023cited by 32position: firstdoi
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
˜The œLancet. Gastroenterology & hepatology 2022cited by 650position: middledoi
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
The Journal of Clinical Endocrinology & Metabolism 2022cited by 295position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Muthiah · National University of Singapore32 papers (2021–2025)Cheng Han Ng · Kurume University27 papers (2021–2024)Mark Y. Chan · National University of Singapore22 papers (2020–2025)Yip Han Chin · Ministry of Health21 papers (2021–2025)Mohammad Shadab Siddiqui · Children's Hospital of Richmond at VCU15 papers (2021–2024)Gwyneth Kong · National University of Singapore15 papers (2022–2025)Wen Hui Lim · National University Hospital15 papers (2021–2022)Darren Jun Hao Tan · National University of Singapore14 papers (2021–2022)Arun J. Sanyal · Center for Systems Biology14 papers (2021–2025)Bryan Chong · National University of Singapore13 papers (2022–2025)Kai En Chan · National University of Singapore13 papers (2022–2025)Mazen Noureddin · Chiang Mai University12 papers (2021–2023)Roger Foo · National University of Singapore11 papers (2021–2024)Daniel Q. Huang · Second Affiliated Hospital of Xi'an Jiaotong University11 papers (2021–2024)Jieling Xiao · Guangzhou Center for Disease Control and Prevention11 papers (2021–2022)Chin-Meng Khoo · National University of Singapore10 papers (2021–2024)Jie Ning Yong · National University of Singapore10 papers (2021–2022)Phoebe Wen Lin Tay · Sengkang General Hospital10 papers (2021–2022)Yock Young Dan · National University of Singapore9 papers (2021–2022)Anurag Mehta · Emory Healthcare9 papers (2023–2025)